908
Views
20
CrossRef citations to date
0
Altmetric
Editorial

CIK cells – current status, clinical perspectives and future prospects – the good news

, PhD FRCPath (UK)
Pages 659-661 | Published online: 14 Apr 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Li Xu, Jun Wang, Yuhree Kim, Ze-yu Shuang, Yao-jun Zhang, Xiang-ming Lao, Yong-qiang Li, Min-shan Chen, Timothy M. Pawlik, Jian-chuan Xia, Sheng-ping Li & Wan-yee Lau. (2016) A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma. OncoImmunology 5:3.
Read now
Qiu-Zhong Pan, Yan Tang, Qi-Jing Wang, Yong-Qiang Li, Li Zhang, Xiao-Dong Li, Jing-Jing Zhao, De-Sheng Weng, Qing Liu, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Yi-Xin Zeng & Jian-Chuan Xia. (2015) Adjuvant cellular immunotherapy in patients with resected primary non-small cell lung cancer. OncoImmunology 4:9.
Read now

Articles from other publishers (18)

Qingming Guo, Zhen Zhang, Peng Zhao, Sen Zou, Linxi Li, Ning Li, Weihong Sun, Xiaofang Wei, Lin Hou, Zhaoyong Yang & Daiqing Gao. (2020) Bispecific antibody activated T cells: A newly developed T cells with enhanced proliferation ability and cytotoxicity. Immunology Letters 220, pages 79-87.
Crossref
Jun Sik Yoon, Byeong Geun Song, Jeong-Hoon Lee, Hyo Young Lee, Sun Woong Kim, Young Chang, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Dong Hyun Sinn, Yoon Jun Kim, Joon Hyeok Lee & Jung-Hwan Yoon. (2019) Adjuvant cytokine-induced killer cell immunotherapy for hepatocellular carcinoma: a propensity score-matched analysis of real-world data. BMC Cancer 19:1.
Crossref
Jiaxue Wang, Tiantian Shen, Qi Wang, Tan Zhang, Lujin Li, Yu Wang & Yi Fang. (2019) The long-term efficacy of cytokine-induced killer cellular therapy for hepatocellular carcinoma: a meta-analysis. Immunotherapy 11:15, pages 1325-1335.
Crossref
Zhibin Li, Xue-Feng Yu & Paul K. Chu. (2018) Recent advances in cell-mediated nanomaterial delivery systems for photothermal therapy. Journal of Materials Chemistry B 6:9, pages 1296-1311.
Crossref
Xiao-yan Fan, Peng-yu Wang, Chao Zhang, Yu-long Zhang, Yun Fu, Cong Zhang, Qiao-xia Li, Jie-na Zhou, Bao-en Shan & Dong-wei He. (2017) All-trans retinoic acid enhances cytotoxicity of CIK cells against human lung adenocarcinoma by upregulating MICA and IL-2 secretion. Scientific Reports 7:1.
Crossref
Zuowei Hu, Xiaoye Zhang, Hang Yang, Shuanglai Qin, Yaqi Liu, Wei Xiong, Bing Yuan, Liping Li, Weiqi Yao & Dongcheng Wu. (2017) Alterations in expression levels of genes in p53‑related pathways determined using RNA‑Seq analysis in patients with breast cancer following CIK therapy. Oncology Letters.
Crossref
Guangzhi He, Chenhong Zheng, Huiping Huo, Huiming Zhang, Zhiquan Zhu, Junlai Li & Hongpeng Zhang. (2016) TACE combined with dendritic cells and cytokine-induced killer cells in the treatment of hepatocellular carcinoma: A meta-analysis. International Immunopharmacology 40, pages 436-442.
Crossref
Joost Hegmans, Lysanne Lievense & Joachim Aerts. 2016. Cancer Genetics and Genomics for Personalized Medicine. Cancer Genetics and Genomics for Personalized Medicine 175 187 .
Chia-Yi Tseng, Chin-Hung Lin, Lung-Yuan Wu, Jhih-Syuan Wang, Meng-Chi Chung, Jing-Fen Chang & Ming-Wei Chao. (2016) Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin. PLOS ONE 11:5, pages e0155469.
Crossref
Tao Lin, Chun Song, Dong-yu Chuo, Hao Zhang & Jian Zhao. (2015) Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study. Tumor Biology 37:4, pages 4367-4372.
Crossref
Lysanne Lievense, Joachim Aerts & Joost Hegmans. 2016. Lung Cancer and Personalized Medicine. Lung Cancer and Personalized Medicine 59 90 .
Shousheng LiuXiaopai WangYing LuJianhong XiaoJiayi LiangXueyun ZhongYunxian Chen. (2015) The Combined Use of Cytokine-Induced Killer Cells and Cyclosporine A for the Treatment of Aplastic Anemia in a Mouse Model. Journal of Interferon & Cytokine Research 35:5, pages 401-410.
Crossref
Qiang Zhang, Xiao-yan Liu, Teng Zhang, Xin-feng Zhang, Lin Zhao, Fei Long, Zhuang-kai Liu & En-hua Wang. (2015) The dual-functional capability of cytokine-induced killer cells and application in tumor immunology. Human Immunology 76:5, pages 385-391.
Crossref
Qiu-Zhong Pan, Qi-Jing Wang, Jia-Qiang Dan, Ke Pan, Yong-Qiang Li, Yao-Jun Zhang, Jing-Jing Zhao, De-Sheng Weng, Yan Tang, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Min-Shan Chen, Max S. Wicha, Alfred E. Chang, Yi-Xin Zeng, Qiao Li & Jian-Chuan Xia. (2015) A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma. Scientific Reports 5:1.
Crossref
Jinying Zhang, Lingjun Zhu, Haina Du, Xiang He, Yongmei Yin, Yanhong Gu, Lianke Liu, Kaihua Lu, Renhua Guo, Ping Liu & Yongqian Shu. (2015) Autologous cytokine-induced killer cell therapy in lung cancer patients: A retrospective study. Biomedicine & Pharmacotherapy 70, pages 248-252.
Crossref
Jinying Zhang, Lingjun Zhu, Qian Zhang, Xiang He, Yongmei Yin, Yanhong Gu, Renhua Guo, Kaihua Lu, Lianke Liu, Ping Liu & Yongqian Shu. (2014) Effects of cytokine-induced killer cell treatment in colorectal cancer patients: A retrospective study. Biomedicine & Pharmacotherapy 68:6, pages 715-720.
Crossref
Ke Pan, Xun-Xing Guan, Yong-Qiang Li, Jing-Jing Zhao, Jian-Jun Li, Hui-Juan Qiu, De-Sheng Weng, Qi-Jing Wang, Qing Liu, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Yi-Xin Zeng & Jian-Chuan Xia. (2014) Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer. Clinical Cancer Research 20:11, pages 3003-3011.
Crossref
Xiaomeng Wang, Wenwen Yu, Hui Li, Jinpu Yu, Xinwei Zhang, Xiubao Ren & Shui Cao. (2014) Can the dual-functional capability of CIK cells be used to improve antitumor effects?. Cellular Immunology 287:1, pages 18-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.